AKT1 and cancer: EGFR signaling has been linked to survivin in many cancer studies [37], and it has been shown that EGFR activates the PI3K/Akt pathway leading to upregulation of HIF-1alpha which subsequently activates survivin gene expression by binding to its promoter region [22].